Global diversity and evidence for coevolution of KIR and HLA

被引:0
|
作者
Richard M Single
Maureen P Martin
Xiaojiang Gao
Diogo Meyer
Meredith Yeager
Judith R Kidd
Kenneth K Kidd
Mary Carrington
机构
[1] University of Vermont,The Department of Mathematics and Statistics
[2] Laboratory of Genomic Diversity,Departamento de Genética e Biologia Evolutiva
[3] SAIC-Frederick,Division of Cancer Epidemiology and Genetics, Department of Health and Human Services
[4] National Cancer Institute-Frederick,Department of Genetics
[5] Universidade de São Paulo,undefined
[6] Core Genotyping Facility,undefined
[7] Advanced Technology Program,undefined
[8] SAIC-Frederick,undefined
[9] Inc.,undefined
[10] National Cancer Institute-Frederick,undefined
[11] National Cancer Institute,undefined
[12] US National Institutes of Health,undefined
[13] Yale University School of Medicine,undefined
来源
Nature Genetics | 2007年 / 39卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The killer immunoglobulin-like receptor (KIR) gene cluster shows extensive genetic diversity, as do the HLA class I loci, which encode ligands for KIR molecules. We genotyped 1,642 individuals from 30 geographically distinct populations to examine population-level evidence for coevolution of these two functionally related but unlinked gene clusters. We observed strong negative correlations between the presence of activating KIR genes and their corresponding HLA ligand groups across populations, especially KIR3DS1 and its putative HLA-B Bw4-80I ligands (r = −0.66, P = 0.038). In contrast, we observed weak positive relationships between the various inhibitory KIR genes and their ligands. We observed a negative correlation between distance from East Africa and frequency of activating KIR genes and their corresponding ligands, suggesting a balance between selection on HLA and KIR loci. Most KIR-HLA genetic association studies indicate a primary influence of activating KIR-HLA genotypes in disease risk1,2; concomitantly, activating receptor-ligand pairs in this study show the strongest signature of coevolution of these two complex genetic systems as compared with inhibitory receptor-ligand pairs.
引用
收藏
页码:1114 / 1119
页数:5
相关论文
共 50 条
  • [31] Co-evolution of KIR2DL3 with HLA-C in a human population retaining minimal essential diversity of KIR and HLA class I ligands
    Gendzekhadze, Ketevan
    Norman, Paul J.
    Abi-Rached, Laurent
    Graef, Thorsten
    Moesta, Achim K.
    Layrisse, Zulay
    Parham, Peter
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (44) : 18692 - 18697
  • [32] Genetic Diversity of the KIR/HLA System and Susceptibility to Hepatitis C Virus-Related Diseases
    De Re, Valli
    Caggiari, Laura
    De Zorzi, Mariangela
    Repetto, Ombretta
    Zignego, Anna Linda
    Izzo, Francesco
    Tornesello, Maria Lina
    Buonaguro, Franco Maria
    Mangia, Alessandra
    Sansonno, Domenico
    Racanelli, Vito
    De Vita, Salvatore
    Pioltelli, Pietro
    Vaccher, Emanuela
    Beretta, Massimiliano
    Mazzaro, Cesare
    Libra, Massimo
    Gini, Andrea
    Zucchetto, Antonella
    Cannizzaro, Renato
    De Paoll, Paolo
    PLOS ONE, 2015, 10 (02):
  • [33] GENETIC DIVERSITY OF THE KIR/HLA SYSTEM AND OUTCOME OF PATIENTS WITH METASTATIC COLORECTAL CANCER TREATED WITH CHEMOTHERAPY
    De Re, V
    Caggiari, L.
    De Zorzi, M.
    Buonadonna, A.
    De Paoli, A.
    Belluco, C.
    Fornasarig, M.
    Maiero, S.
    Orzes, E.
    Cannizzaro, R.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E83 - E84
  • [34] Diversity of KIR, HLA Class I, and Their Interactions in Seven Populations of Sub-Saharan Africans
    Nemat-Gorgani, Neda
    Guethlein, Lisbeth A.
    Henn, Brenna M.
    Norberg, Steven J.
    Chiaroni, Jacques
    Sikora, Martin
    Quintana-Murci, Lluis
    Mountain, Joanna L.
    Norman, Paul J.
    Parham, Peter
    JOURNAL OF IMMUNOLOGY, 2019, 202 (09): : 2636 - 2647
  • [35] Genetic Diversity of the KIR/HLA System and Outcome of Patients with Metastatic Colorectal Cancer Treated with Chemotherapy
    De Re, Valli
    Caggiari, Laura
    De Zorzi, Mariangela
    Talamini, Renato
    Racanelli, Vito
    D'Andrea, Mario
    Buonadonna, Angela
    Zagonel, Vittorina
    Cecchin, Erika
    Innocenti, Federico
    Toffoli, Giuseppe
    PLOS ONE, 2014, 9 (01):
  • [36] KIR and HLA ligands demonstrate genetic inheritance diversity in Japanese descendants from Parana, Brazil
    de Alencar, Josiane Bazzo
    Valentini Zacarias, Joana Maira
    da Silva Guedes de Moura, Barbara Leticia
    Braga, Marco Antonio
    Laguila Visentainer, Jeane Eliete
    Sell, Ana Maria
    HUMAN IMMUNOLOGY, 2018, 79 (04) : 191 - 192
  • [37] KIR GENE FREQUENCIES AND KIR/HLA COMBINATIONS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
    Khamaganova, Ekaterina G.
    Chugreeva, Tamara P.
    Parovichnikova, Elena N.
    TISSUE ANTIGENS, 2012, 79 (06): : 590 - 590
  • [38] KIR and HLA class I diversity in Pakistani and Yadav populations: a high-resolution study of immunogenetic diversity in South Asians
    Kichula, Katherine M.
    Harrison, Genelle F.
    Nelson, Cassie
    Piluso, Allison
    Freed, Brian M.
    Aubrey, Michael
    Hameed, K. M.
    Norman, Paul J.
    JOURNAL OF IMMUNOLOGY, 2021, 206
  • [39] HLA and KIR Associations of Cervical Neoplasia
    Bao, Xiao
    Hanson, Aimee L.
    Madeleine, Margaret M.
    Wang, Sophia S.
    Schwartz, Stephen M.
    Newell, Felicity
    Pettersson-Kymmer, Ulrika
    Hemminki, Kari
    Tiews, Sven
    Steinberg, Winfried
    Rader, Janet S.
    Castro, Felipe
    Safaeian, Mahboobeh
    Franco, Eduardo L.
    Coutlee, Francois
    Ohlsson, Claes
    Cortes, Adrian
    Marshall, Mhairi
    Mukhopadhyay, Pamela
    Cremin, Katie
    Johnson, Lisa G.
    Garland, Suzanne M.
    Tabrizi, Sepehr N.
    Wentzensen, Nicolas
    Sitas, Freddy
    Trimble, Cornelia
    Little, Julian
    Cruickshank, Maggie
    Frazer, Ian H.
    Hildesheim, Allan
    Brown, Matthew A.
    Duncan, Emma L.
    Sun, YingPu
    Leo, Paul J.
    JOURNAL OF INFECTIOUS DISEASES, 2018, 218 (12): : 2006 - 2015
  • [40] HLA AND KIR GENES IN GAUCHER DISEASE
    Filippo Vairo, F. V.
    Portela, P. P.
    Patricia, S. P. H.
    Netto, C. B. N.
    Mittelstadt, S. M.
    Jobim, L. F. J.
    Schwartz, I. V. D. S.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2012, 35 : S101 - S101